CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 14 enrolled
Drug / intervention
RO7017773 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03774576
NCT03774576Phase 1Completed
CompareCT.gov

A Non-Randomized, Open Label, One Sequence, Two-Period Cross-Over Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Participants

Hoffmann-La Roche·interventional·Posted Dec 13, 2018·Updated May 7, 2020

In Brief

A Phase 1 clinical trial evaluating RO7017773 and Itraconazole for Healthy Volunteers. Completed, enrolled 14 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate the effect of multiple oral doses of itraconazole on the pharmacokinetics of RO7017773 in healthy volunteers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesFrance
Collaborators--

Timeline

Phase 1CompletedFinished
20192020202120222023202420252026
First PostedDec 13, 2018
Enrollment StartDec 17, 2018
Primary CompletionMar 14, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.6 years ago

Interventions

RO7017773drug

Single doses of RO7017773

Itraconazoledrug

Multiple doses of Itraconazole